Literature DB >> 1483796

Acetazolamide and high altitude diseases.

A R Bradwell1, A D Wright, M Winterborn, C Imray.   

Abstract

Acetazolamide is a useful prophylactic for acute mountain sickness causing marked reduction in headache, nausea, vomiting, weakness, etc. Improvements correlate with increased arterial oxygen concentrations, reduction in proteinuria and peripheral oedema and other objective measures of acute mountain sickness. Evidence that Acetazolamide is beneficial for pulmonary oedema or cerebral oedema is scanty because of the lower frequency of these severe forms of mountain sickness. Dexamethasone, used prophylactically, also reduces the symptoms of acute mountain sickness partly due to its euphoric effect. Use of Acetazolamide as a treatment for established acute mountain sickness has been investigated. Large doses of Acetazolamide increase arterial oxygen levels over a few hours and this leads to a reduction of symptoms but data is limited and faster acting carbonic anhydrides inhibitors such as Methazolamide may be preferable in an emergency situation. There is no comparison of the effectiveness of Acetazolamide with other drugs used for treating acute mountain sickness such as steroids and calcium channel blocking drugs. Also, there is no data on drug combinations which could have additive effects and thereby be more beneficial than individual drugs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483796     DOI: 10.1055/s-2007-1024597

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  3 in total

Review 1.  Effects of altitude on mood, behaviour and cognitive functioning. A review.

Authors:  M S Bahrke; B Shukitt-Hale
Journal:  Sports Med       Date:  1993-08       Impact factor: 11.136

2.  Toward the Discovery of a Novel Class of Leads for High Altitude Disorders by Virtual Screening and Molecular Dynamics Approaches Targeting Carbonic Anhydrase.

Authors:  Amena Ali; Abuzer Ali; Musarrat Husain Warsi; Mohammad Akhlaquer Rahman; Mohamed Jawed Ahsan; Faizul Azam
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

Review 3.  Carbonic Anhydrases as Potential Targets Against Neurovascular Unit Dysfunction in Alzheimer's Disease and Stroke.

Authors:  Nicole Lemon; Elisa Canepa; Marc A Ilies; Silvia Fossati
Journal:  Front Aging Neurosci       Date:  2021-11-16       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.